CN110338221A - Highland barley highland barley compound for reducing blood suger - Google Patents
Highland barley highland barley compound for reducing blood suger Download PDFInfo
- Publication number
- CN110338221A CN110338221A CN201910761900.0A CN201910761900A CN110338221A CN 110338221 A CN110338221 A CN 110338221A CN 201910761900 A CN201910761900 A CN 201910761900A CN 110338221 A CN110338221 A CN 110338221A
- Authority
- CN
- China
- Prior art keywords
- highland barley
- reducing blood
- compound
- food
- blood suger
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000007340 Hordeum vulgare Nutrition 0.000 title claims abstract description 57
- 239000008280 blood Substances 0.000 title claims abstract description 38
- 210000004369 blood Anatomy 0.000 title claims abstract description 38
- 150000001875 compounds Chemical class 0.000 title claims abstract description 21
- 241000209219 Hordeum Species 0.000 title 2
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 55
- 239000000843 powder Substances 0.000 claims abstract description 20
- 244000302512 Momordica charantia Species 0.000 claims abstract description 14
- 235000009811 Momordica charantia Nutrition 0.000 claims abstract description 14
- 235000009812 Momordica cochinchinensis Nutrition 0.000 claims abstract description 13
- 235000018365 Momordica dioica Nutrition 0.000 claims abstract description 13
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 12
- 229920001202 Inulin Polymers 0.000 claims abstract description 12
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 12
- 229940029339 inulin Drugs 0.000 claims abstract description 12
- 240000007594 Oryza sativa Species 0.000 claims abstract description 11
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 11
- 239000008103 glucose Substances 0.000 claims abstract description 11
- 235000016709 nutrition Nutrition 0.000 claims abstract description 11
- 235000009566 rice Nutrition 0.000 claims abstract description 11
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 10
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000007199 Panicum miliaceum Nutrition 0.000 claims abstract description 10
- 244000022185 broomcorn panic Species 0.000 claims abstract description 10
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 10
- 235000013312 flour Nutrition 0.000 claims abstract description 10
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 7
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 7
- 235000013976 turmeric Nutrition 0.000 claims abstract description 7
- 235000013336 milk Nutrition 0.000 claims abstract description 6
- 239000008267 milk Substances 0.000 claims abstract description 6
- 210000004080 milk Anatomy 0.000 claims abstract description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 5
- 206010012601 diabetes mellitus Diseases 0.000 claims description 28
- 235000014375 Curcuma Nutrition 0.000 claims description 5
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims description 5
- 235000020183 skimmed milk Nutrition 0.000 claims description 5
- 239000004615 ingredient Substances 0.000 claims description 2
- 235000005979 Citrus limon Nutrition 0.000 claims 1
- 244000131522 Citrus pyriformis Species 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 21
- 239000002994 raw material Substances 0.000 abstract description 11
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract description 9
- 238000000034 method Methods 0.000 abstract description 5
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 abstract description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 235000010447 xylitol Nutrition 0.000 abstract description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 abstract description 4
- 229960002675 xylitol Drugs 0.000 abstract description 4
- 239000000811 xylitol Substances 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 3
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 2
- 230000036186 satiety Effects 0.000 abstract description 2
- 235000019627 satiety Nutrition 0.000 abstract description 2
- 235000010216 calcium carbonate Nutrition 0.000 abstract 1
- 235000015165 citric acid Nutrition 0.000 abstract 1
- 235000013339 cereals Nutrition 0.000 description 12
- 239000000203 mixture Substances 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000005520 cutting process Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 108010007622 LDL Lipoproteins Proteins 0.000 description 2
- 102000007330 LDL Lipoproteins Human genes 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000023852 carbohydrate metabolic process Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 208000004104 gestational diabetes Diseases 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 244000241257 Cucumis melo Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000013016 Hypoglycemia Diseases 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000009815 Momordica Nutrition 0.000 description 1
- 241000218984 Momordica Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000031662 Noncommunicable disease Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 230000010159 dioecy Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229940036630 folic acid 0.2 mg Drugs 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003538 tetroses Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/37—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/198—Dry unshaped finely divided cereal products, not provided for in groups A23L7/117 - A23L7/196 and A23L29/00, e.g. meal, flour, powder, dried cereal creams or extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses highland barley highland barley compound for reducing blood suger, disclose a kind of preparation method and application of low GI food highland barley highland barley hypoglycemic tabletting food, belong to field of food, raw material includes highland barley flour, oatmeal, broom corn millet rice, milk powder, inulin, antierythrite, xylitol, balsam pear, turmeric, calcium carbonate, citric acid.The product is finely divided according to crowd and fortification, it is difficult to meet the nutritional need and taste demand of different groups.After food obtained is measured according to glucose resultant index human experimentation measuring method as defined in IS026642:2010, show that its GI value less than 55, belongs to low GI food.Not only nutrition is delicious but also satiety is strong for the tabletting food, it is often more important that this congee solves the problems, such as to be difficult to low GIization by reasonably formula collocation.
Description
Technical field
The invention belongs to food processing technology fields, and in particular to a kind of highland barley highland barley compound for reducing blood suger.
Background technique
With living-pattern preservation and the aggravation of aging of population, diabetes have become China after tumour, angiocarpy
The 3rd Chronic Non-Communicable Diseases after disease.According to statistics, 2013, China's diabetes prevalence had reached 10.4%, at
People diabetic sum about 1.144 hundred million, it has also become suffer from the most country of diabetes number in the world.Meanwhile the hair of diabetes
The gradually rejuvenation of sick age.It is shown according to one in 2012 for 25376 teen-age diabetes investigation, 2012
Chinese 7-17 years old childhood and adolescence diabetes illness rate is 0.52%, and growth rate is more obvious.In addition to this, pregnant woman is also
The group that cannot ignore in diabetes patient.Gestational diabetes mellitus is perinatal period common complication, the current gestation sugar in China
Urinating sick incidence is 1.31%-3.75%, and has the tendency that rising year by year.
For diabetes patient due to carbohydrate metabolism disturbance, regulating and controlling blood sugar ability is poor, and it is higher to be not suitable for the GI values such as intake pure white rice and flour
Cereal, therefore the selection of staple food is particularly important for diabetes patient.The GI value of full paddy coarse cereals is low, and Density of nutrient is high, diet
Fiber content is high, and satiety is strong, is very suitable to diabetes patient as staple food.But due to coarse cereals close structure, cook complicated, portion
Diabetes patient such as office worker, student etc. is divided to be difficult to as staple food.It is convenient after powder is made in coarse cereals, it is reconstituted with boiled water
?.But due to destroying its structure, GI value can accordingly rise, it is therefore desirable to reduce meal by the rich protein-contg raw material of addition
Blood glucose response afterwards.
Children, pregnant woman and the middle-aged and the old have nothing in common with each other for the demand of nutrient, but there is no roots for existing coarse cereals product
It is finely divided according to crowd and fortification, it is difficult to meet the nutritional need and taste demand of different groups.
Summary of the invention
The present invention relates to a kind of highland barley highland barley compound for reducing blood suger, it is characterised in that the weight of component is are as follows: highland barley flour 4.5-
5.5g, oatmeal 2.5-3.5g, broom corn millet rice 2.5-3.5g, milk powder 1.5-2.5g, inulin 0.5- 1.5g, antierythrite 0.5-
1.5g, inulin 0.5-1.5g, balsam pear 100-150mg, turmeric 30-45mg.
The present invention relates to a kind of highland barley highland barley compound for reducing blood suger, it is characterised in that: it is preferably ginger that balsam pear, which is preferably balsam pear powder, turmeric,
Bloom.
The present invention relates to a kind of highland barley highland barley compound for reducing blood suger, it is characterised in that: also includes calcium carbonate 150- 200mg, citric acid
150-200mg。
The present invention relates to highland barley highland barley compound for reducing blood suger, which is characterized in that the parts by weight of the diabetes nutritional ingredient are as follows:
Highland barley flour 4g, skimmed milk power 2g, broom corn millet rice 3g, oatmeal 3g, 0.1 g of balsam pear powder, curcuma powder 0.03g, antierythrite 1g, inulin
1g。
The present invention relates to highland barley highland barley compound for reducing blood suger, which is characterized in that with the glucose of edible equal quality after intake, can show
Writing reduces blood glucose level.
The present invention relates to highland barley highland barley compound for reducing blood suger, which is characterized in that is finely divided according to crowd (children, pregnant woman, old man)
And fortification, it is difficult to meet the nutritional need and taste demand of different groups.
The present invention relates to highland barley highland barley compound for reducing blood suger, it is characterised in that use independent bag, 15 grams every bag.
The present invention relates to highland barley highland barley compound for reducing blood suger, it is characterised in that edible way is instant bagged.
The present invention relates to a kind of highland barley highland barley compound for reducing blood suger, raw material components include: highland barley flour 5g, oatmeal according to quality
3g, broom corn millet rice 2g, milk powder 2g, inulin 2g, antierythrite 1g, xylitol 1g, balsam pear 0.5g, turmeric 0.5g.
Moreover, it relates to which a kind of highland barley highland barley compound for reducing blood suger, finished product are preferred: containing protein in every 100g
21.2g, fatty 3g, carbohydrate 68.3g, wherein dietary fiber 15g.
It should know, oatmeal, which refers to, to be carried out crushing obtained powder with complete oat.
Above-mentioned broom corn millet rice, is Chinese tradition staple food, can make a variety of wheaten food, other opposite staple food grains are rich in VB1, VB2, VE,
It is more suitable for being in the children and adolescents in the period of growing up to eat as staple food grain and other food pairings.
Above-mentioned milk powder is that milk sloughs powder made of moisture, contains alpha lactalbumin, is easier to absorb；Probiotics and prebiotics
Combination promote function of intestinal canal；DHA promotes brain development.
It is raw material by cutting pre-cooked manufactured cereal-granules that above-mentioned oat grain, which includes: preferably using full oat, therein
Protein, fat, lysine content are high；It is also rich in linoleic acid, long-term consumption can reduce accumulation of the cholesterol in angiocarpy,
For preventing senile hypertension, diabetes, hyperlipidemia etc. of great advantage.And there is oat the medical treatment such as anti-cancer, treatment constipation to make
With.
It is raw material by cutting pre-cooked manufactured cereal-granules that above-mentioned highland barley grains, which include: preferably using highland barley, rich in a variety of
Phenolic compound, flavone compound, beta glucan, γ-aminobutyric acid, can be effectively reduced cholesterol and low-density lipoprotein
(LDL) content and atherosclerosis index, it is anti-oxidant, reduce cardiovascular and cerebrovascular disease risk.
The natural oligofructose of deposit property in plant in above-mentioned inulin, is conducive to control blood lipid rich in dietary fiber, reduces blood
Sugar value, promotes the absorption of minerals, adjusts intestinal microflora, inhibits the generation of toxic fermentation nothing, protects liver, prevent just
It is secret.
Above-mentioned antierythrite is a kind of tetrose alcohol newly developed, can be made, zero calory, be had certain by glucose fermentation
Sweet taste can be used as generation sugar, improve food mouthfeel without causing blood glucose to rise.
Above-mentioned xylitol is the intermediate of human body carbohydate metabolism, in the case of lacking insulin influence glycometabolism in vivo, nothing
Palpus insulin promotes, and xylitol can also penetrate cell membrane, be absorbed by tissue utilization, promotes liver glycogen synthesis, for cell with nutrition
And energy, and blood glucose value will not be caused to increase, more than three symptoms after diabetes patient takes (more foods, more drinks, diuresis) is eliminated, is most
Be suitble to the table sugar of the trophism of patients with diabetes mellitus replaces product.
Above-mentioned balsam pear is any kind vegetables on the market, wherein (every hectogram dioecism momordica root contains polypeptide to substance containing bitter gourd polypeptide
Substance 25mg), polypeptides matter play the role of significantly reducing blood glucose, adjust blood lipid, improve the effect of immunity.Thus seek
It is the good medicine for treating diabetes that feeding scholar and doctor, which recommend balsam pear,.The middle-aged and the old with diabetes can take mountain hardship for a long time
Melon tea raises treatment.There are good inhibition and adjustment effect to blood lipid, blood pressure, blood glucose and obesity.
Above-mentioned turmeric is the powder worn into the dry rhizome of turmeric, has reducing blood lipid, antitumor, anti-inflammatory, strengthen immunity
Effect.
Another aspect of the invention provides the production method of the applicable low GI tabletting food of diabetes, is obtained using the production method
The low GI tabletting food arrived has compared with adequate nutrition structure.
A method of production such as above-mentioned low GI tabletting food mixes each raw material
The advantageous effects of the above technical solutions of the present invention are as follows: low GI tabletting food has compared drug, it is a kind of more strong
The mode of health, cheap, convenient control blood glucose, can not only supplement other nutrients such as certain good protein, moreover it is possible to pass through
The intake that load reduces dinner before the meal reduces the occurrence probability of hypoglycemia to control postprandial blood sugar well.
Composition of the invention can be preferably prepared to generation meal grain dust.
Composition of the invention has the advantage that
First, the postprandial blood sugar index of diabetic can be effectively improved, while providing partially protein and micro battalion
Element is supported, the nutritional need of diabetic is met.
Second, avoiding the hunger of diabetic due to containing higher dietary fiber and high density starch, making him
Handle more abundant, the amount kept on a diet.
Third, being directed to different types of diabetic, specially treated is carried out to nutrition, more meets the health of different crowd
Demand.
Fourth, materials are extensive, cheap, easy to use.
Certainly, the above description is not a limitation of the present invention, and the present invention is also not limited to the example above, the art
Those of ordinary skill, any variation, addition or the replacement made within the essential scope of the present invention also should belong to of the invention
Protection scope.
Specific embodiment
Embodiment 1
Highland barley flour 4g, skimmed milk power 2g, broom corn millet rice 3g, oatmeal 3g, balsam pear powder 0.1g, curcuma powder 0.03g, antierythrite
1g, inulin 1g, cocoa power 1g.
It is thoroughly mixed through above-mentioned raw materials, obtains the composition that diabetes patient is applicable in.It is preferred that congenital type ii diabetes children.
Embodiment 2
Highland barley flour 4g, skimmed milk power 2g, broom corn millet rice 3g, oatmeal 3g, balsam pear powder 0.1g, curcuma powder 0.03g, antierythrite
1g, inulin 1g, calcium carbonate 0.2g, citric acid 0.2g, folic acid 0.2mg, vitamin C 0.2mg, calcium carbonate 0.1mg
It is thoroughly mixed through above-mentioned raw materials, obtains the composition that diabetes patient is applicable in.It is preferred that gestational diabetes mellitus women.
Embodiment 3:
Highland barley flour 4g, skimmed milk power 2g, broom corn millet rice 4g, oatmeal 3g, balsam pear powder 0.1g, curcuma powder 0.03g, antierythrite
1g, inulin 1g.
It is thoroughly mixed through above-mentioned raw materials, obtains the composition that advanced age diabetes patient is applicable in.
Embodiment 4:
The preferred process of the component of composition of the invention.
Embodiment 5:
The process of the analysis condition of the component of composition of the invention.
Embodiment 6:
The preferred preparation process of oat grain: it is used using full oat as raw material by cutting pre-cooked manufactured cereal-granules.
Embodiment 7:
The preferred preparation process of highland barley grains: being preferably raw material by cutting pre-cooked manufactured cereal-granules using highland barley,
Embodiment 8: the present invention has good effect, is especially effectively improved the postprandial blood sugar index of diabetic.
Claims (7)
1. a kind of highland barley highland barley compound for reducing blood suger, it is characterised in that the weight of component is are as follows: highland barley flour 4.5-5.5g, oatmeal 2.5-
3.5g, broom corn millet rice 2.5-3.5g, milk powder 1.5-2.5g, inulin 0.5-1.5g, antierythrite 0.5-1.5g, inulin 0.5-1.5g,
Balsam pear 100-150mg, turmeric 30-45mg.
2. a kind of highland barley highland barley compound for reducing blood suger according to claim 1, it is characterised in that: also include calcium carbonate 150-200mg, lemon
Sour 150-200mg.
3. highland barley highland barley compound for reducing blood suger according to claim 1, which is characterized in that the weight of the diabetes nutritional ingredient
Number are as follows: highland barley flour 4g, skimmed milk power 2g, broom corn millet rice 3g, oatmeal 3g, balsam pear powder 0.1g, curcuma powder 0.03g, antierythrite
1g, inulin 1g.
4. highland barley highland barley compound for reducing blood suger according to claim 1 to 2, which is characterized in that after intake with the Portugal of edible equal quality
Grape sugar, can significantly reduce blood glucose level.
5. highland barley highland barley compound for reducing blood suger according to claim 1, which is characterized in that according to crowd (children, pregnant woman, old man) into
Row subdivision and fortification, it is difficult to meet the nutritional need and taste demand of different groups.
6. highland barley highland barley compound for reducing blood suger according to claim 1, it is characterised in that use independent bag, 15 grams every bag.
7. highland barley highland barley compound for reducing blood suger according to claim 1, it is characterised in that edible way is instant bagged.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910761900.0A CN110338221A (en) | 2019-08-19 | 2019-08-19 | Highland barley highland barley compound for reducing blood suger |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910761900.0A CN110338221A (en) | 2019-08-19 | 2019-08-19 | Highland barley highland barley compound for reducing blood suger |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110338221A true CN110338221A (en) | 2019-10-18 |
Family
ID=68180660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910761900.0A Pending CN110338221A (en) | 2019-08-19 | 2019-08-19 | Highland barley highland barley compound for reducing blood suger |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110338221A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110800994A (en) * | 2019-10-25 | 2020-02-18 | 武汉轻工大学 | Compound nutrient for reducing values of blood sugar, urine sugar and glycosylated hemoglobin and preparation method thereof |
| CN110810694A (en) * | 2019-11-14 | 2020-02-21 | 王艳辉 | Special blood sugar reducing solid beverage for diabetic patients and preparation and use methods thereof |
| CN113287658A (en) * | 2021-04-28 | 2021-08-24 | 青海华实科技投资管理有限公司 | Highland barley cereal meal replacement milkshake powder capable of assisting in reducing hypertension, hyperlipidemia and hyperglycemia and preparation method thereof |
-
2019
- 2019-08-19 CN CN201910761900.0A patent/CN110338221A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110800994A (en) * | 2019-10-25 | 2020-02-18 | 武汉轻工大学 | Compound nutrient for reducing values of blood sugar, urine sugar and glycosylated hemoglobin and preparation method thereof |
| CN110810694A (en) * | 2019-11-14 | 2020-02-21 | 王艳辉 | Special blood sugar reducing solid beverage for diabetic patients and preparation and use methods thereof |
| CN113287658A (en) * | 2021-04-28 | 2021-08-24 | 青海华实科技投资管理有限公司 | Highland barley cereal meal replacement milkshake powder capable of assisting in reducing hypertension, hyperlipidemia and hyperglycemia and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20210352948A1 (en) | Composition for treating diabetes based on traditional Chinese medicine nutritional therapy and application thereof | |
| CN101564159B (en) | Food for reducing hypertension and diabetes and preparation method thereof | |
| CN101836709B (en) | Tartary buckwheat noodles and preparation method thereof | |
| CN104431741B (en) | Cereal conditioning porridge and making method and application thereof | |
| CN104432084A (en) | Conditioning powder and preparation method and application thereof | |
| CN102067960A (en) | Health-care rice suitable for diabetics and processing method thereof | |
| CN105995993A (en) | Food composition applicable to diabetic and preparation method thereof | |
| WO2006016701A1 (en) | Agent for preventing/ameliorating diabetes and functional food for preventing/ameliorating diabetes | |
| CN104643080B (en) | Combined formula of three-day food exchange body shaping product and eating method | |
| CN103168812A (en) | Sugar-free tartary buckwheat biscuit and manufacture method thereof | |
| CN110338221A (en) | Highland barley highland barley compound for reducing blood suger | |
| CN1193688C (en) | Food for regulating blood fat and blood sugar with haw powder and balsam pear powder as material | |
| CN108142938A (en) | Control special medicine purposes formula food meal replacement powder of blood glucose and preparation method thereof | |
| CN110800904A (en) | Solid beverage composition capable of effectively controlling weight and reducing fat and preparation method thereof | |
| CN105707696A (en) | Coarse cereal nutrition noodles | |
| CN109998118A (en) | A kind of functional nutrient breakfast cereal | |
| CN108391785A (en) | A kind of functionality meal replacement powder and its manufacture craft and application | |
| CN110973613A (en) | Plant composite powder composition suitable for weight-losing crowd, product suitable for weight-losing crowd and application | |
| KR101184666B1 (en) | Composition for improving physiological activity of positive constitution | |
| CN104544401A (en) | Protein solid drink suitable for diabetic patients | |
| CN101828678B (en) | Highland barley-sesame paste and preparation method thereof | |
| KR20210051478A (en) | Easy-to-eat of Nutrition Balance Health Food | |
| CN106360463A (en) | Sugar-free, high-fiber and high-protein siraitia grosvenorii convenient food and preparation method thereof | |
| CN109170863A (en) | A kind of functional sugar ferment and preparation method thereof | |
| CN107397213A (en) | A kind of nutritional supplementation meal powder of diabetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20191018 |
|
| WD01 | Invention patent application deemed withdrawn after publication |